[1] FENG J A. Target research on tumor biology characteristics of mir-155-5p regulation on gastric cancer cell[J]. Pak J Pharm Sci, 2016, 29(2):711-718.
[2] DEBRUYNE D N, TURCHI L, BUREL-VANDENBOS F, et al. DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression[J]. Oncogene, 2018, 37(2):241-254.
[3] LV K T, LIU Z, FENG J, et al. MiR-22-3p regulates cell proliferation and inhibits cell apoptosis through targeting the eIF4EBP3 gene in human cervical squamous carcinoma cells[J]. Int J Med Sci, 2018, 15(2):142-152.
[4] WANG Y Y, CONG W, WU G, et al. MiR-376a suppresses the proliferation and invasion of non-small-cell lung cancer by targeting c-Myc[J]. Cell Biol Int, 2018, 42(1):25-33.
[5] YU Z H, TENG M, SUN A J, et al. Virus-encoded miR-155 ortholog is an important potential regulator but not essential for the development of lymphomas induced by very virulent Marek's disease virus[J]. Virology, 2014, 448:55-64.
[6] WANG Y. The inhibition of microRNA-15a suppresses hepatitis B virus-associated liver cancer cell growth through the Smad/TGF-β pathway[J]. Oncol Rep, 2017, 37(6):3520-3526.
[7] KANG B W, CHOI Y, KWON O K, et al. High level of viral microRNA-BART20-5p expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer[J]. Oncotarget, 2017, 8(9):14988-14994.
[8] CALNEK B W. Marek's disease——a model for herpesvirus oncology[J]. Crit Rev Microbiol, 1986, 12(4):293-320.
[9] CHI J Q, TENG M, YU Z H, et al. Marek's disease virus-encoded analog of microRNA-155 activates the oncogene c-Myc by targeting LTBP1 and suppressing the TGF-β signaling pathway[J]. Virology, 2015, 476:72-84.
[10] ZHAO P, LI X J, TENG M, et al. In vivo expression patterns of microRNAs of Gallid herpesvirus 2(GaHV-2) during the virus life cycle and development of Marek's disease lymphomas[J]. Virus Genes, 2015, 50(2):245-252.
[11] BURNSIDE J, OUYANG M, ANDERSON A, et al. Deep sequencing of chicken microRNAs[J]. BMC Genomics, 2008, 9:185.
[12] YAO Y X, ZHAO Y G, SMITH L P, et al. Differential expression of microRNAs in Marek's disease virus-transformed T-lymphoma cell lines[J]. J Gen Virol, 2009, 90(Pt 7):1551-1559.
[13] LIAN L, QU L J, CHEN Y M, et al. A systematic analysis of miRNA transcriptome in Marek's disease virus-induced lymphoma reveals novel and differentially expressed miRNAs[J]. PLoS One, 2012, 7(11):e51003.
[14] LI X, LIAN L, ZHANG D X, et al. gga-miR-26a targets NEK6 and suppresses Marek's disease lymphoma cell proliferation[J]. Poult Sci, 2014, 93(5):1097-1105.
[15] LIAN L, LI X, ZHAO C F, et al. Chicken gga-miR-181a targets MYBL1 and shows an inhibitory effect on proliferation of Marek's disease virus-transformed lymphoid cell line[J]. Poult Sci, 2015, 94(11):2616-2621.
[16] ZHUANG G Q, SUN A J, TENG M, et al. A tiny RNA that packs a big punch:The critical role of a viral miR-155 ortholog in lymphomagenesis in Marek's disease[J]. Front Microbiol, 2017, 8:1169, doi:10. 3389/fmicb. 2017. 01169.
[17] GU J Y, LU Z S, JI C H, et al. Melatonin inhibits proliferation and invasion via repression of miRNA-155 in glioma cells[J]. Biomed Pharmacother, 2017, 93:969-975.
[18] WEI R J, ZHANG C H, YANG W Z. MiR-155 affects renal carcinoma cell proliferation, invasion and apoptosis through regulating GSK-3β/β-catenin signaling pathway[J]. Eur Rev Med Pharmacol Sci, 2017, 21(22):5034-5041.
[19] YAN Z Y, CHE S S, WANG J P, et al. miR-155 contributes to the progression of glioma by enhancing Wnt/β-catenin pathway[J]. Tumor Biol, 2015, 36(7):5323-5331.
[20] LIU F, SONG D L, WU Y H, et al. MiR-155 inhibits proliferation and invasion by directly targeting PDCD4 in non-small cell lung cancer[J]. Thorac Cancer, 2017, 8(6):613-619.
[21] MENG X F, NIU J J, YANG Y L, et al. Downregulation of miR-155 inhibits proliferation and enhances chemosensitivity to Temozolomide in glioma cells[J]. Int J Clin Exp Pathol, 2017, 10(2):1303-1312.
[22] YAO Y X, VASOYA D, KGOSANA L, et al. Activation of gga-miR-155 by reticuloendotheliosis virus T strain and its contribution to transformation[J]. J Gen Virol, 2017, 98(4):810-820. |